A Student Club Conference at Harvard Business School
A Student Club Conference at Harvard Business School
Healthcare Innovations for Driving Consumers to ActionThe impact of chronic disease is increasing at a rapid pace around the globe. Against this backdrop, pioneering approaches have emerged to empower consumers to take charge of their own health while improving outcomes and reducing health care costs. These approaches include focusing on preventative care, altering consumer spending patterns, and empowering the aging population. Our panel will illustrate, debate, and explore the different pathways to motivate consumers to take ownership of their health. Moderator:Jason Riis, Assistant Professor, Harvard Business School Panelists:Luke Matthews, PhD, Director of Data Analytics, Activate Networks
Marcus Osborne, Vice President, Health & Wellness Payer Relations, Wal-Mart
Stuart Slutzky, Chief, Product Innovation, HumanaVitality
Dustin Humphreys, Senior Director, CVS.com
Chris Hocevar, President, U.S. Select Segment, CIGNA Corporation
|
Re-evaluating Medical Device Usage in a Cost Conscious EnvironmentIn an environment in which all stakeholders in the healthcare system are becoming economically constrained, medical device purchases and utilization are under increasingly higher scrutiny. The decision about which and when to use a medical device has evolved into a complex problem. Payers, providers, regulators, and even consumers now weigh the costs and benefits of using devices. The increase in healthcare costs is forcing changes in the decision making process around medical devices usage, transforming many medical practices as we know them today. Industry experts and leaders from prominent device and diagnostics organizations will share their viewpoints on how this issue will affect the research & development, sales & marketing, usage and associated outcomes of these products. Moderator:Steve Chao, MD, PhD, Partner, ClearView Healthcare Partners Panelists:Joseph V. Gulfo, MD, President and CEO, Mela Sciences
Alan Levy, PhD, CEO, Incline Therapeutics
William Huyett, Director, McKinsey and Company Erik Halvorsen, PhD, Executive Director, Technology and Innovation Development Office, Children’s Hospital Boston
|
How to Sustainably Increase Access to Care in Emerging Markets?Devising methods to deliver care to patients in emerging markets is a growing concern in the global healthcare context. Given the diversity of global healthcare models and substantial cost pressures, manufacturers and providers are challenged in achieving the overall mission of providing access to care. Our panel will invite discussion about how access to care is improving and how various stakeholders can be incentivized to sustain this growth. Additionally, we will highlight various low cost delivery models and address challenges that these approaches face. Regions of focus will include: India, Latin America, Middle East, and Africa. Moderator:Pepe Guevara, Partner and Managing Director, The Boston Consulting Group Panelists:Marc Harrison, MD, CEO, Cleveland Clinic Abu Dhabi |
Healthcare Information Technology is Increasing Transparency – Can It Empower You?Healthcare information technology (HCIT) companies are working to increase transparency around costs, efficacy, and access to care. By empowering the consumer with these data, they can make informed choices about their care. The effect will be dazzling. When it comes to healthcare, the consumer is typically left in the dark. These companies are providing light. But many questions remain: Who will pay for it? When will this information be available? How do we know this data is providing an accurate view? And once the information is out there – will consumers actually change their behavior? Moderator:Brice Baradel, Executive Director, UBS Panelists:Graham Gardner, MD, Kyruus
Richard Migliori, MD, Executive Vice President, UnitedHealth Group
Josh Stevens, CEO, Keas
Sarah Milby, Business Development, Castlight Health
|
Early Stage Funding: Reorienting towards Consumer-Driven Healthcare SolutionsThis panel will explore the evolving funding landscape in healthcare ventures, from an emphasis on biotech/devices to consumer-centric healthcare solutions (including wellness, IT and services). Venture Capitalist from a variety of backgrounds will share their views on the sustainability of the VC model in life sciences, the value-added of consumer-centric healthcare, and the implications of this “biotech to consumer” shift for patients, entrepreneurs and investors. Panelists will also discuss implications for VC firms themselves – from hiring decisions to fundraising and valuations. Moderator:Ambar Bhattacharyya, Vice President, Bessemer Panelists:Jon Lim, Principal, Fidelity Biosciences
Charles Huang, Vice President, Private Equity Operations Group, Blackstone Brad Weinberg, MD, Founding Partner, Blueprint Health
Paulina Hill, PhD, Senior Associate, Polaris Venture Partners
|
Payer and Provider Disruption: Shift towards Consumer ChoiceThe health care market is undergoing a new wave of consumer-focused disruption in both health insurance and health care delivery. First, the shift from large purchasers of group health insurance to less sophisticated purchasers of individual benefits will empower consumers to make purchasing decisions. Second, the emerging collaboration between providers and payers will move health care toward consumer-directed care, quality transparency, and Accountable Care Organizations. Our panel will discuss the impact of these disruptions on payers, providers and end consumers by exploring various questions such as: How can incumbent payers position themselves to take advantage of the shift towards individual consumer insurance? Who are some market entrants that may pose threats to health insurance incumbents? What are the some challenges that providers will face due this disruption? What collaboration is taking place between providers and payers as a reaction to healthcare consumerism? And how will the advent of Accountable Care Organizations affect consumers? Moderator:Regina Herzlinger, Nancy R. McPherson Professor of Business Administration, Harvard Business School Panelists:Thomas Henry Lee, MD, Network President, Partners Healthcare System, CEO, Partners Community HealthCare |
Finding the Fit: Role of Diagnostics in Drug Development and TreatmentThis panel will explore the impact of new diagnostics on the drug development process. Specifically, panelists from entrepreneurial, industrial, academic and financing backgrounds will share their involvement in drug development, their perspectives on the speed of adoption in the industry and what they see the as the role of diagnostics going forward. They will address issues including reimbursement challenges, ethical issues, physician adoption, key disease areas of interest, and main barriers to mass adoption of an integrated approach. Moderator:Vikas Goyal, Senior Associate, SR One Panelists:Gary Palmer, MD, Senior Vice President, Medical Affairs and Commercial Development, Foundation Medicine |
Targeted Relationships: Biopharma’s Evolving Strategies for Engaging PatientsAs the biopharmaceutical industry embraces niche markets and moves away from the blockbuster model, it must also re-evaluate the way in which it engages patients. No longer will direct-to-consumer advertising and broad sweeping sales forces effectively reach increasingly targeted patient populations. Consumers may be difficult to find, let alone engage, and relationships with non-traditional customers such as patient advocacy groups could increase in priority. Industry experts from both prominent biotechnology and pharmaceutical companies will discuss how their organizations’ relationships and interactions with patients have evolved. The panel will share insights into the patient-focused strategies they have employed, as well as the various challenges and opportunities this evolving dynamic presents. Moderator:Matthew Riordan, Partner, Putnam Associates Panelists:Navin Katyal, Chief of Staff, US Primary Care Business Unit, Pfizer
Kate Haviland, Head of Commercial Development, Sarepta Therapeutics Joseph Leveque, MD, Head, US Medical Oncology, Bristol Myers Squibb John Bamforth, PhD, BPharm, Chief Marketing Officer, US Business, Eli Lilly Ann Miller, Vice President, Global Marketing, Sanofi Oncology
|
MBA Student Experiences with China’s Healthcare SystemChina’s health sector faces significant challenges in delivering care and incentivizing best practices; at the same time, the country offers tremendous opportunities for healthcare innovation and entrepreneurship as Chinese consumers rapidly increase their health spending. A group of HBS students, led by HBS Professor Arthur Daemmrich, will be going to China over the winter to evaluate: how China can improve care quality and satisfy demands for broader access, what forms of private insurance would complement the public system, what financing system will sustain rapid progress in pharmaceutical, biotechnology, and medical device research, and what regulatory innovations will improve quality and safety. The students will also investigate the potential for Chinese firms in the health sector to become independent global players. HBS students will share their experiences and key learning about the Chinese healthcare system and the opportunities for entrepreneurship and innovation. Moderator:Mark Philipps, Chief Marketing Officer, GE Healthcare, previously Chief Marketing Officer for Asia Pacific Panelists, Harvard Business School Second-Year MBA Students:Louisa Malkin, Hospitals
Judith Li, Finance
Michael Kemmer, IT in Healthcare
Margaret Terry, Insurance
Shirley Leong, Medical Devices
Jonah Bernstein, Pharmaceuticals
|